Seeking Alpha

Recursion Pharmaceuticals: Upgrading To Buy - My Most Surprising Call Of 2025

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
IEEE

Deadlock Resolution and Recursive Feasibility in MPC-Based Multirobot Trajectory Generation

Abstract: Online collision-free trajectory generation within a shared workspace is fundamental for most multirobot applications. However, many widely-used methods based on model predictive control ...
stockstelegraph

Recursion Pharmaceuticals, Inc. (RXRX): JP Morgan Upgrades to Overweight with Significant Upside Potential

Recursion Pharmaceuticals, Inc. (RXRX) recently received a notable upgrade from JP Morgan analyst Eric Joseph, who shifted his rating to “Overweight” on December 17, 2025. This upgrade comes as the ...
Education Week

Do Schools Put College Prep and CTE on Equal Footing? We Asked Educators

Many high schools for years have maintained two separate tracks for students: the college-bound path for students who took traditional academic classes and the “vo-tech” path for kids who spent at ...
Seeking Alpha

Recursion jumps as J.P. Morgan upgrades on lead program

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...